Oakhurst Medicaid spent at least $4,055 on COVID-19 care in 2024

At least $4,055 in Medicaid payments were made in Oakhurst in 2024 for services billed under HCPCS codes identified as COVID-19-related, according to the U.S. Department of Health and Human Services Medicaid Provider Spending database.

Medicaid, a public health insurance initiative funded by both federal and state governments and administered by states, provides coverage for low-income Americans, seniors, children, and individuals with disabilities. It is a major part of health care delivery in the U.S.

Because Medicaid draws from public funds, shifts in local billing help illustrate how health care resources are distributed in each community.

For this report, COVID-19–related services were determined through HCPCS codes labeled or categorized as “COVID-19” or “coronavirus”-related in billing details or reference information. As such, these totals only reflect services specifically flagged as COVID-related in claims data and exclude any pandemic-related care billed under broader or alternative codes.

By comparison, Clifton recorded New Jersey’s highest total in Medicaid payments for COVID-19 services in 2024, at $1,725,516 in related claims.

Genesis Laboratory Management, LLC was the sole provider submitting Medicaid claims for COVID-19–related services in Oakhurst in 2024, data shows.

During the pandemic years, services specific to COVID-19 represented a significant portion of growth in Oakhurst’s Medicaid spending.

All other Medicaid payments increased by $951,961 between 2020 and 2024, marking a 132% rise.

Average annual Medicaid payments in Oakhurst reached $1,296,408 during the two years preceding the pandemic.

According to the Centers for Medicare & Medicaid Services, total federal and state spending on Medicaid was about $871.7 billion in fiscal year 2023, making up roughly 18% of all national health expenditures—an increase from approximately $613.5 billion in 2019 before the onset of COVID-19.

This change illustrates about 40% growth over several years, mainly due to increased enrollment and greater utilization both during and after the pandemic period.

Recent federal budget actions during the Trump administration have proposed major reductions to federal Medicaid funding and program restructuring. The “One Big Beautiful Bill Act,” signed into law in 2025, is projected to reduce federal Medicaid expenditures by over $1 trillion in the next decade and introduces changes such as work requirements and more cost-sharing, which could affect coverage and state funding. These measures are likely to increase the financial responsibility of states while capping future federal Medicaid support—even as Medicaid continues to insure millions across the U.S.

Note: Includes HCPCS codes explicitly labeled for COVID-19 services; totals do not represent all pandemic-related health care spending.

Information for this story was drawn from the U.S. Department of Health and Human Services Medicaid Provider Spending database. See the source data here.